Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-10 11:58 am Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 8,223,994 10.2% | 1,803,258 (+28.08%) | View |
| 2024-02-12 6:22 pm Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Nikko Asset Management Americas Inc. | 3,369,762 4.24% | -636,714 (-15.89%) | View |
| 2024-02-09 6:03 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 6,420,736 8.1% | 860,244 (+15.47%) | View |
| 2024-02-05 06:08 am Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Sumitomo Mitsui Trust Holdings Inc. | 3,369,762 4.24% | -636,714 (-15.89%) | View |
| 2024-01-29 4:00 pm Unchanged | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 8,536,104 10.75% | 0 (Unchanged) | View |
| 2024-01-10 11:36 am Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 8,536,104 10.75% | 545,916 (+6.83%) | View |
| 2023-04-10 9:17 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 7,990,188 10.16% | 160,256 (+2.05%) | View |
| 2023-02-13 3:54 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 5,560,492 7.1% | 1,854,488 (+50.04%) | View |
| 2023-02-10 12:25 pm Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 7,829,932 10% | -1,257,936 (-13.84%) | View |
| 2023-02-10 10:30 am Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Nikko Asset Management Americas Inc. | 4,006,476 5.11% | -312,995 (-7.25%) | View |
| 2023-02-03 06:10 am Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Sumitomo Mitsui Trust Holdings Inc. | 4,006,476 5.11% | -312,995 (-7.25%) | View |
| 2022-02-14 06:05 am Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Nikko Asset Management Americas Inc. | 4,319,471 5.64% | 482,648 (+12.58%) | View |
| 2022-02-11 11:19 am Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 3,706,004 4.8% | -558,998 (-13.11%) | View |
| 2022-02-09 2:29 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 9,087,868 11.88% | 1,443,518 (+18.88%) | View |
| 2022-02-04 06:05 am Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Sumitomo Mitsui Trust Holdings Inc. | 4,319,471 5.64% | 482,648 (+12.58%) | View |
| 2021-09-10 2:47 pm Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 7,644,350 10.03% | -2,768,626 (-26.59%) | View |
| 2021-08-10 12:28 pm Sale | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 4,265,002 5.6% | -3,361,353 (-44.08%) | View |
| 2021-02-16 4:33 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | ARK Investment Management LLC | 10,412,976 14.62% | 1,955,656 (+23.12%) | View |
| 2021-02-16 3:58 pm Purchase | 13G | CRISPR THERAPEUTICS AG NAMEN A CRSP | Capital International Investors | 7,626,355 10.7% | 106,552 (+1.42%) | View |
| 2021-02-16 07:33 am Purchase | 13D | CRISPR THERAPEUTICS AG NAMEN A CRSP | Versant Ventures IV LLC | 1,344,010 1.9% | 1,344,010 (New Position) | View |